Skip to content
Clinical Trials – home

Mast cell activation syndrome Basic Information

0 / 1 trials open to patients1 country

In short

Mast Cell Activation Syndrome (MCAS) is a puzzling condition where the immune system's "police officers" – mast cells – sound the alarm without a real threat, causing sudden and severe reactions throughout the body. Unlike typical allergies that have clear triggers, MCAS episodes can strike unpredictably, affecting multiple body systems at once and sometimes leading to life-threatening emergencies.

Key points

  • MCAS causes severe, unpredictable reactions affecting multiple body systems without clear triggers, unlike typical allergies where you know what caused the reaction.
  • The condition involves mast cells releasing over 1,000 different chemical mediators inappropriately, explaining why symptoms can be so varied and affect virtually any part of the body.
  • Many people with MCAS go years without diagnosis because symptoms fluctuate, mimic other conditions, and routine tests often appear normal between episodes.
  • Common triggers include temperature changes, stress, certain foods, fragrances, and exercise – but triggers vary greatly between individuals and can change over time.
  • A low-histamine diet, avoiding personal triggers, and managing stress can significantly reduce symptom frequency and severity for many people with MCAS.
  • MCAS can sometimes run in families and may be associated with genetic conditions, suggesting hereditary factors play a role in some cases.
  • Emergency preparedness is crucial – people with MCAS should always carry prescribed emergency medications and inform others about their condition.
  • While there's no cure, most people with MCAS can achieve good symptom control through a combination of trigger avoidance, dietary changes, and medications that block mast cell mediators.

Understanding Mast Cell Activation Syndrome

Mast Cell Activation Syndrome is a condition where your body experiences repeated, intense episodes of symptoms that seem to come out of nowhere. These episodes can include swelling, shortness of breath, skin reactions like hives, digestive problems such as diarrhea and vomiting, and many other uncomfortable or dangerous symptoms. What makes MCAS particularly challenging is that these reactions happen without a clear or obvious trigger, unlike typical allergic reactions where you know exactly what caused the problem – like eating peanuts if you're allergic to them.

The condition gets its name from mast cells, which are special immune cells found throughout your body's tissues. These cells act like security guards, constantly watching for threats such as parasites, viruses, or harmful substances. When they detect danger, they release chemicals called mediators – including histamine and tryptase – to activate your immune system and fight off the perceived invader. In healthy people, this is a helpful protective response. But in people with MCAS, these mast cells become overly sensitive and release their chemicals too frequently or in response to things that aren't actually harmful, such as temperature changes, certain foods, or fragrances.

MCAS is different from another mast cell condition called mastocytosis. In mastocytosis, there are too many mast cells in the body due to abnormal growth, and these cells can be identified under a microscope by specific markers. MCAS patients, on the other hand, have normal-looking mast cells that simply misbehave. The mast cells in MCAS release mediators spontaneously or become unusually sensitive to activation, but they don't meet the strict laboratory criteria used to diagnose mastocytosis.

To confirm a diagnosis of MCAS, doctors look for several key features. First, you must have repeated episodes where symptoms affect two or more body systems at the same time – for example, your skin and your digestive system, or your breathing and your heart. Second, tests must show evidence that mast cell mediators are being released during these episodes, typically by measuring a rise in substances like tryptase in your blood. Third, your symptoms must improve when you take medications that block these mast cell mediators, such as antihistamines. Finally, other conditions that could explain your symptoms must be ruled out.

How Common Is MCAS?

For many years, mast cell activation syndrome was thought to be extremely rare. However, recent research suggests that MCAS may actually be much more common than previously believed. The condition is now recognized as likely being considerably prevalent, meaning many people may have it without knowing. This is partly because MCAS can be difficult to diagnose – symptoms vary widely between patients, they can come and go unpredictably, and routine laboratory tests often come back normal even when someone is experiencing significant problems.

MCAS can develop in both children and adults, and there's evidence that it sometimes runs in families, suggesting genetic factors may play a role. For example, some people with MCAS also have a genetic condition called hereditary alpha tryptasemia syndrome (HATS), which is caused by having extra copies of a specific gene. Because the symptoms of MCAS can affect almost any part of the body and often mimic other conditions, many people go years – or even their entire lives – without receiving a proper diagnosis.

The condition affects people regardless of age or sex, though specific statistics on who is most commonly affected are still being studied. What researchers do know is that MCAS should be considered in anyone who has chronic symptoms affecting multiple body systems, especially when those symptoms come in episodes and no other clear diagnosis explains everything the patient is experiencing.

What Causes Mast Cell Activation Syndrome?

The exact cause of MCAS is not yet fully understood, but researchers have identified several factors that contribute to the condition. At the heart of MCAS is a malfunction in how mast cells behave. Normally, mast cells respond to genuine threats like infections or injuries. In MCAS, however, these cells become defective and release their mediators because of abnormal internal signals rather than in response to actual danger.

Scientists have discovered that certain mutations – changes in genes – can affect mast cells and make them overly active. These mutations can occur in genes that control important cell functions, particularly genes for proteins called kinases that help regulate cell behavior. When these genes are altered, mast cells can form populations of identical cells (called clones) that overproduce and spontaneously release mediators without proper control. This spontaneous release is called "primary activation," meaning it comes from within the cells themselves rather than being triggered by something external.

In some cases, MCAS appears to have a genetic component. The condition sometimes occurs in family groups, suggesting it can be inherited. One well-characterized genetic cause is hereditary alpha tryptasemia syndrome, where people have extra copies of the alpha tryptase gene. Because the genetic causes of some forms of mast cell disease are now known, genetic testing is available for certain conditions, though not all forms of MCAS have identified genetic markers yet.

Another factor contributing to MCAS is that mast cells in affected individuals may have decreased rates of apoptosis – the natural cell death process that normally helps regulate cell numbers. When mast cells don't die off at the normal rate, they can accumulate in tissues even though they look normal under a microscope. These accumulated cells are more likely to release mediators inappropriately.

Risk Factors for Developing MCAS

While anyone can potentially develop MCAS, certain factors may increase the risk. Having a family history of MCAS or related mast cell disorders suggests a genetic predisposition. People who have other mast cell conditions, such as mastocytosis or hereditary alpha tryptasemia syndrome, are also at higher risk of experiencing mast cell activation symptoms.

The relationship between MCAS and other conditions is complex. Some research suggests that mast cell dysfunction may play a role in other poorly understood conditions such as idiopathic anaphylaxis (severe allergic reactions with no known cause), certain forms of fibromyalgia, irritable bowel syndrome, and interstitial cystitis (a painful bladder condition). While not everyone with these conditions has MCAS, the overlap suggests that abnormal mast cell activity may contribute to symptoms in some patients.

Environmental exposures and infections may also play a role in triggering or worsening MCAS in susceptible individuals. However, unlike traditional allergies where a specific allergen consistently causes reactions, MCAS triggers are often unpredictable and can change over time for the same person. This variability makes it difficult to identify specific risk factors beyond genetic predisposition.

Recognizing the Symptoms of MCAS

The symptoms of MCAS can affect virtually any part of the body, which is why the condition can be so challenging to diagnose. For MCAS to be considered, symptoms must affect at least two different body systems at the same time. These symptoms typically come in episodes or "flares" that can last for varying amounts of time, and the severity can range from merely bothersome to life-threatening.

Skin symptoms are among the most common manifestations of MCAS. These include flushing (where the skin becomes hot, red, or pink), intense itching, hives, and swelling. The swelling, called angioedema, often affects the face, lips, eyes, tongue, or throat. Unlike typical skin rashes that might be caused by contact with an irritant, these skin symptoms in MCAS can appear suddenly and without obvious cause.

The digestive system is frequently affected in MCAS. People may experience abdominal pain, nausea, vomiting, and diarrhea. Some people have constipation instead, or may alternate between diarrhea and constipation. These digestive symptoms can be severe enough to significantly impact daily life and nutrition.

Respiratory symptoms include nasal congestion, shortness of breath, and in severe cases, difficulty breathing due to airway constriction. Cardiovascular symptoms can include low blood pressure, rapid heartbeat, and in extreme cases, cardiovascular collapse. These symptoms can cause weakness, dizziness, or fainting.

Many people with MCAS describe their episodes as feeling similar to severe allergic reactions. However, the key difference is that these reactions happen without a clear allergen exposure. The unpredictability of symptoms is one of the most distressing aspects of living with MCAS – you never quite know when an episode might occur or how severe it will be.

Additional symptoms can include headaches, brain fog or difficulty concentrating, bone pain, muscle pain, and fatigue. Because MCAS affects multiple systems and symptoms can be vague or fluctuating, many patients see numerous doctors and undergo many tests before receiving a correct diagnosis.

Preventing MCAS Episodes

While there is no way to prevent MCAS itself, people with the condition can take steps to reduce the frequency and severity of episodes. The cornerstone of prevention is identifying and avoiding personal triggers as much as possible. This requires careful observation and often keeping a detailed diary of symptoms, activities, foods, environmental exposures, and other factors that might be related to flares.

Common triggers reported by people with MCAS include sudden temperature changes (both heat and cold), stress, fatigue, certain foods, alcohol, medications, fragrances and chemicals in personal care products or household cleaners, exercise, and infections. Some people also react to insect stings, changes in weather, or even sunlight exposure. The specific triggers vary greatly between individuals, and importantly, a person's triggers can change over time.

Many people with MCAS find that following a low-histamine diet helps reduce symptoms. This means avoiding foods that are naturally high in histamine or that trigger histamine release in the body. High-histamine foods include aged or fermented foods (like aged cheeses, cured meats, sauerkraut, and yogurt), leftover foods (histamine increases as food ages), alcohol (especially wine and beer), canned fish, pickled foods, certain fruits (citrus, strawberries, tomatoes), nuts, chocolate, and foods containing preservatives like sodium benzoate.

Managing stress is another important preventive strategy. Stress can directly activate mast cells and cause them to release mediators. Finding effective ways to manage stress through relaxation techniques, adequate sleep, and maintaining a regular routine can help reduce the frequency of MCAS episodes.

Environmental modifications can also help. Using fragrance-free personal care products and household cleaners, installing high-quality air purifiers in the home, avoiding exposure to cigarette smoke and other air pollutants, and controlling temperature and humidity in living spaces can all reduce exposure to common mast cell triggers.

Getting adequate sleep and maintaining a consistent daily routine helps support the body's natural cycles and may reduce mast cell activation. People with MCAS often find that their symptoms worsen when they're tired or when their normal routine is disrupted.

How MCAS Affects the Body

Understanding what happens in the body during MCAS helps explain why the symptoms are so varied and can affect so many different systems. The root of the problem lies in how mast cells function and what happens when they malfunction.

Mast cells are found throughout the body, particularly in tissues that interface with the external environment – the skin, the lining of the airways and digestive tract, and around blood vessels. They're strategically positioned to detect threats early. Each mast cell is packed with hundreds of small storage sacs called granules that contain preformed mediators like histamine. When a mast cell is activated, these granules fuse with the cell membrane and release their contents in a process called degranulation. The cell can also manufacture and release additional mediators after activation.

Histamine, one of the most important mediators, causes blood vessels to dilate (widen) and become leaky, which leads to swelling, redness, and low blood pressure. It makes nerve endings more sensitive, causing itching and pain. In the airways, histamine causes muscles to contract, narrowing the airways and making breathing difficult. In the digestive tract, it increases acid production and speeds up gut movement, leading to cramping and diarrhea.

Tryptase is an enzyme that's found almost exclusively in mast cells, which is why measuring its levels in the blood is useful for diagnosing mast cell activation. Other mediators released by mast cells include cytokines (chemical messengers that signal other immune cells), leukotrienes (which also cause airway constriction and inflammation), prostaglandins (involved in pain and inflammation), and many others. There are over 1,000 different mediators that can be released by mast cells.

In MCAS, mast cells release these mediators too frequently or in excessive amounts. This can happen spontaneously due to internal abnormalities in the cells themselves, or because the cells have become hypersensitive to normal stimuli. The wide distribution of mast cells throughout the body explains why MCAS symptoms can affect so many different organs and systems. When mast cells throughout the body release their mediators simultaneously, the result can be a systemic reaction affecting the skin, respiratory system, cardiovascular system, and digestive system all at once.

The abnormal mast cell behavior in MCAS can stem from genetic mutations that affect the cells' internal signaling pathways. These pathways normally tightly control when and how much mediator is released. When mutations disrupt these controls, cells become prone to spontaneous activation. Additionally, in MCAS, mast cells may not die off at normal rates, leading to accumulation of these dysfunctional cells in tissues over time.

The body does have mechanisms to break down histamine and other mediators once they're released. Enzymes like diamine oxidase (DAO) help metabolize histamine. However, if these enzymes aren't functioning optimally – due to genetic variations, nutrient deficiencies, or other factors – histamine and other mediators can build up to higher levels, worsening symptoms. This is why some people with MCAS find that taking DAO supplements helps reduce their symptoms.

Did you know?

  1. Mast cells contain over 1,000 different chemical mediators, not just histamine, which explains why MCAS symptoms can be so diverse and why antihistamines alone don't always provide complete relief.
  2. Some people with MCAS react to their own body's temperature changes – even the warmth generated by exercise or a hot shower can trigger a reaction, making simple daily activities challenging.
  3. MCAS may be linked to several other mysterious conditions including some cases of chronic fatigue syndrome, fibromyalgia, and irritable bowel syndrome, suggesting mast cell dysfunction could be an underlying cause of multiple poorly understood illnesses.

Questions people often ask

This guide is here to help you understand the condition. It does not replace a conversation with your doctor, who knows your situation best.

Clinical trials for Mast cell activation syndrome

Recruiting trials first

See all 1 trials →
Quick filters

1 clinical trial in this condition

Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Masitinib
  • Sponsor:Ab Science
See all 1 trials →filters applied: condition = Mast cell activation syndrome

Related conditions in the same therapeutic area

Back to all diseases
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.

Legal notice · Published by CTIN POLAND sp. z o.o., ul. rtm. Witolda Pileckiego 67/109, 02-781 Warsaw, Poland · KRS 0001111334 · REGON 528919042 · NIP 9512598637

© 2026 Clinical Trials EU – European Clinical Trials Information Network

GDPR compliance, ISO 9001 and ISO 27001 certified (LL-C Certification)

On this site, “treatment” means an investigational medicine being studied in a clinical trial. Its safety and efficacy for the use being studied have not yet been confirmed, some participants may receive a placebo or a comparator medicine, and taking part does not guarantee any health benefit. The decision to take part is made by the doctor at the research site. This site is for information only and does not replace medical advice.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic sites, national regulators and commercial sponsors. On this site, “treatment” and “therapy” mean a medicine being tested in a clinical trial. Its safety and effectiveness in the use being studied are not yet confirmed, some participants may receive a placebo or a comparator, and taking part does not guarantee a health benefit. The doctor at the research site decides who can take part. This site provides information, not medical advice. Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).